ADRIENNE SHAVER: Open Payments
NPI 1659595742 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 12 payments from 8 companies in 2025. Trend: 2023 $2,496 · 2024 $2,428 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Biocon Biologics Inc | 1 | $14 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, VEGZELMA, CREON, ENTYVIO, Yesintek.
Industry payments across UT — which companies pay providers there.
